» Articles » PMID: 34002634

Impact of Presymptomatic COVID-19 on Vascular and Skeletal Muscle Function: a Case Study

Overview
Date 2021 May 18
PMID 34002634
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The impact of COVID-19 has been largely described after symptom development. Although the SARS-CoV-2 virus elevates heart rate (HR) prior to symptom onset, whether this virus evokes other presymptomatic alterations is unknown. This case study details the presymptomatic impact of COVID-19 on vascular and skeletal muscle function in a young woman [24 yr, 173.5 cm, 89 kg, body mass index (BMI): 29.6 kg·m]. Vascular and skeletal muscle function were assessed as part of a separate study with the first and second visits separated by 2 wk. On the evening following the second visit, the participant developed a fever and a rapid antigen test confirmed a positive COVID-19 diagnosis. Compared with the first visit, the participant presented with a markedly elevated HR (∼30 beats/min) and a lower mean blood pressure (∼8 mmHg) at the second visit. Vascular function measured by brachial artery flow-mediated dilation, reactive hyperemia, and passive leg movement were all noticeably attenuated (25%-65%) as was leg blood flow during knee extension exercise. Muscle strength was diminished as was ADP-stimulated respiration (30%), assessed in vitro, whereas there was a 25% increase in the apparent Km. Lastly, an elevation in IL-10 was observed prior to symptom onset. Notably, 2.5 mo after diagnosis symptoms of fatigue and cough were still present. Together, these findings provide unique insight into the physiological responses immediately prior to onset of COVID-19 symptoms; they suggest that SARS-CoV-2 negatively impacts vascular and skeletal muscle function prior to the onset of common symptoms and may set the stage for the widespread sequelae observed following COVID-19 diagnosis. This unique case study details the impact of SARS-CoV-2 infection on vascular and skeletal muscle function in a young predominantly presymptomatic woman. Prior to COVID-19 diagnosis, substantial reductions in vascular, skeletal muscle, and mitochondrial function were observed along with an elevation in IL-10. This integrative case study indicates that the presymptomatic impact of COVID-19 is widespread and may help elucidate the acute and long-term sequelae of this disease.

Citing Articles

Impact of low-load resistance exercise with and without blood flow restriction on muscle strength, endurance, and oxidative capacity: A pilot study.

Davis B, Stampley J, Granger J, Scott M, Allerton T, Johannsen N Physiol Rep. 2024; 12(12):e16041.

PMID: 38888154 PMC: 11184470. DOI: 10.14814/phy2.16041.


Effect of physical activity on long COVID fatigue: an unsolved enigma.

Coscia F, Di Filippo E, Gigliotti P, Fano Illic G Eur J Transl Myol. 2023; 33(3).

PMID: 37667865 PMC: 10583148. DOI: 10.4081/ejtm.2023.11639.


Musculoskeletal involvement: COVID-19 and post COVID 19.

Evcik D Turk J Phys Med Rehabil. 2023; 69(1):1-7.

PMID: 37201006 PMC: 10186015. DOI: 10.5606/tftrd.2023.12521.


Electrical stimulation to regain lower extremity muscle perfusion and endurance in patients with post-acute sequelae of SARS CoV-2: A randomized controlled trial.

Zulbaran-Rojas A, Lee M, Bara R, Flores-Camargo A, Spitz G, Finco M Physiol Rep. 2023; 11(5):e15636.

PMID: 36905161 PMC: 10006649. DOI: 10.14814/phy2.15636.


Tracking peripheral vascular function for six months in young adults following SARS-CoV-2 infection.

Province V, Szeghy R, Stute N, Augenreich M, Behrens C, Stickford J Physiol Rep. 2022; 10(24):e15552.

PMID: 36541342 PMC: 9768737. DOI: 10.14814/phy2.15552.


References
1.
Thijssen D, Black M, Pyke K, Padilla J, Atkinson G, Harris R . Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. Am J Physiol Heart Circ Physiol. 2010; 300(1):H2-12. PMC: 3023245. DOI: 10.1152/ajpheart.00471.2010. View

2.
Wang F, Hou H, Luo Y, Tang G, Wu S, Huang M . The laboratory tests and host immunity of COVID-19 patients with different severity of illness. JCI Insight. 2020; 5(10). PMC: 7259533. DOI: 10.1172/jci.insight.137799. View

3.
Disser N, De Micheli A, Schonk M, Konnaris M, Piacentini A, Edon D . Musculoskeletal Consequences of COVID-19. J Bone Joint Surg Am. 2020; 102(14):1197-1204. PMC: 7508274. DOI: 10.2106/JBJS.20.00847. View

4.
Natarajan A, Su H, Heneghan C . Assessment of physiological signs associated with COVID-19 measured using wearable devices. NPJ Digit Med. 2020; 3(1):156. PMC: 7705652. DOI: 10.1038/s41746-020-00363-7. View

5.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506. PMC: 7159299. DOI: 10.1016/S0140-6736(20)30183-5. View